President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

By enabling seamless financial services through APIs, BaaS fosters innovation, reduces costs, and enhances customer ...

New York, NY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- KernelDAO, a top restaking protocol with over $2 billion in Total Value ...

We recently published an article titled Why These 15 AI Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Agora Inc (NASDAQ:API) stands against the other ...

If implemented, this initiative could be a game-changer. Industry insiders estimate that Bangladesh could save $1 billion in foreign currency annually by reducing its reliance on imported APIs ...

Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, ...

SoftBank has committed to spending $3 billion per year to use OpenAI’s tech, according to a joint release released on Monday.

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

One of the well-known pharmaceutical businesses, Sigachi Industries Limited (NSE: SIGACHI), has announced the inauguration of ...

Given rising software spending, growing demand, increasing strategic partnerships, and rapid digital transformation, the SAAS ...

ICICI Securities recommended hold rating on Alembic Pharma with a target price of Rs 925 in its research report dated4, 2025.

Alembic Pharmaceuticals tumbled 3.43% to Rs 905 after the company's consolidated net profit tumbled 23.29% to Rs 138.42 crore in Q3 FY25, compared with Rs 180.45 crore posted in Q3 FY24.